Danil Pollack - 28 Oct 2021 Form 4 Insider Report for Bespoke Extracts, Inc. (BSPK)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
4
Accepted by SEC
01 Nov 2021, 08:59:35 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Danil Pollack

Key filing fact

Danil Pollack filed Form 4 for Bespoke Extracts, Inc. (BSPK) on 01 Nov 2021.

Key facts

  • This page summarizes Danil Pollack's Form 4 filing for Bespoke Extracts, Inc. (BSPK).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 01 Nov 2021, 08:59.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: -$40,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSPK transaction

Common Stock

Sale

Transaction value
$40,000
Shares
-50,000,000
Change %
-40%
Price
$0.000800*
Shares after
76,000,000
Date
28 Oct 2021
Ownership
Direct
Footnotes
F1
BSPK transaction

Series C Preferred Stock

Sale

Transaction value
$0
Shares
-1
Change %
-100%
Price
$0.000000*
Shares after
0
Date
28 Oct 2021
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On October 28, 2021, the Reporting Person entered into a stock purchase agreement with a third party for the sale by the Reporting Person of 50,000,000 shares of common stock and 1 share of Series C Preferred Stock of the Issuer for an aggregate purchase price of $40,000. The closing of the sale is subject to certain conditions set forth in the purchase agreement, including the filing and mailing of a Schedule 14f at least 10 days prior to closing.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .